- Report of Foreign Issuer (6-K)
May 03 2012 - 11:19AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities
Exchange Act of 1934
For the month
of May 2012
FRESENIUS
MEDICAL CARE AG & Co. KGaA
(Translation
of registrant’s name into English)
Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
S
Form 40-F
£
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate
by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
£
No
S
If
“Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82
On
May 3, 2012 Fresenius Medical Care AG & Co. KGaA (the “Company”) issued an Investor News announcing its first
quarter results for the period ending March 31, 2012. A copy of the Investor News is furnished as Exhibit 99.1.
The
attached Investor News contains non-GAAP financial measures. For purposes of Regulation G, a non-GAAP financial measure is a numerical
measure of a company’s performance, financial position, or cash flows that either excludes or includes amounts that are
not normally excluded or included in the most directly comparable measure calculated and presented in accordance with generally
accepted accounting principles. To supplement our first quarter 2012 consolidated financial results presented in accordance with
Generally Accepted Accounting Principles in the United States, or GAAP, we have used non-GAAP financial measure of (a) EBITDA,
or operating income excluding interest, taxes, depreciation and amortization, and (b) free cash flow. These non-GAAP measures
are provided to enhance the user’s overall understanding of our current financial performance and our prospects for the
future. In addition, because we have historically reported certain non-GAAP financial measures in our financial results, we believe
the inclusion of these non-GAAP financial measures provides consistency and comparability in our financial reporting to prior
periods for which these non-GAAP financial measures were previously reported. These non-GAAP financial measures should not be
used as a substitute for or be considered superior to GAAP financial measures. Reconciliation of the non-GAAP financial measures
to the most comparable GAAP financial measures are included in the attached Investor News in a separate statement setting forth
the reconciliation and in the Cash Flow Statement.
The
Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act
of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language
in such filing.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
DATE:
May 3, 2012
|
|
|
|
|
Fresenius
Medical Care AG & Co. KGaA,
|
|
a
partnership limited by shares, represented by:
|
|
|
|
fresenius
medical care management ag
, its
|
|
General
Partner
|
|
|
|
|
|
By:
|
/s/
Dr. Ben J. Lipps
|
|
|
Name:
|
Dr.
Ben J. Lipps
|
|
|
Title:
|
Chief
Executive Officer and Chairman of the Management Board of the General Partner
|
|
|
|
|
|
By:
|
/s/
Michael Brosnan
|
|
|
Name:
|
Michael
Brosnan
|
|
|
Title:
|
Chief
Financial Officer and Member of the Management Board of the General Partner
|
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Mar 2023 to Mar 2024